Importantly, SIRT1-dependent control of Th9 cells differentiation appears to have a key role on anti-tumor immunity and allergic pulmonary inflammation [47], suggesting that targeting sirtuins could be exploited as potential therapies for inflammatory and autoimmune diseases. The gene discussed is SIRT1; the disease is autoimmune disease.